These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35949359)

  • 1. Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes.
    Nallicheri A; Mahoney KM; Gutow HA; Bellini N; Isaacs D
    touchREV Endocrinol; 2022 Jun; 18(1):27-34. PubMed ID: 35949359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.
    Lewis DM; Hussain S
    Diabetes Ther; 2022 Sep; 13(9):1683-1699. PubMed ID: 35913655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial.
    Wilkinson T; Tomic D; Boyle E; Burren D; Elghattis Y; Jenkins A; Keesing C; Middleton S; Nanayakkara N; Williman J; de Bock M; Cohen ND
    BMJ Open; 2024 Feb; 14(2):e078171. PubMed ID: 38382954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    BMC Med; 2024 Apr; 22(1):175. PubMed ID: 38659016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control.
    Yoo JH; Kim JH
    Diabetes Metab J; 2023 Jan; 47(1):27-41. PubMed ID: 36635028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials.
    Godoi A; Reis Marques I; Padrão EMH; Mahesh A; Hespanhol LC; Riceto Loyola Júnior JE; de Souza IAF; Moreira VCS; Silva CH; Miyawaki IA; Oommen C; Gomes C; Silva AC; Advani K; de Sa JR
    Diabetol Metab Syndr; 2023 Sep; 15(1):190. PubMed ID: 37759290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTEGRATED INSULIN PUMP AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGY IN DIABETES CARE TODAY: A PERSPECTIVE OF REAL-LIFE EXPERIENCE WITH THE MINIMED
    Aleppo G; Webb KM
    Endocr Pract; 2018 Jul; 24(7):684-692. PubMed ID: 30048171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Experience With Automated Insulin Pump Technology in Veterans With Type 1 Diabetes.
    Amole M; Whyte L; Ghayee HK; Bril F; Cusi K; Leey-Casella J
    Fed Pract; 2021 Nov; 38(Suppl 4):S4-S8. PubMed ID: 35136338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Care of Patients Using Wearable Diabetes Devices.
    Cruz P; McKee AM; Chiang HH; McGill JB; Hirsch IB; Ringenberg K; Wildes TS
    Anesth Analg; 2024 Jun; ():. PubMed ID: 38913575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.
    McAuley SA; de Bock MI; Sundararajan V; Lee MH; Paldus B; Ambler GR; Bach LA; Burt MG; Cameron FJ; Clarke PM; Cohen ND; Colman PG; Davis EA; Fairchild JM; Hendrieckx C; Holmes-Walker DJ; Horsburgh JC; Jenkins AJ; Kaye J; Keech AC; King BR; Kumareswaran K; MacIsaac RJ; McCallum RW; Nicholas JA; Sims C; Speight J; Stranks SN; Trawley S; Ward GM; Vogrin S; Jones TW; O'Neal DN
    BMJ Open; 2018 Jun; 8(6):e020274. PubMed ID: 29886443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg Diabetes Prospective Follow-up Database Registry.
    van den Boom L; Auzanneau M; Woelfle J; Sindichakis M; Herbst A; Meraner D; Hake K; Klinkert C; Gohlke B; Holl RW
    J Diabetes Sci Technol; 2024 Sep; 18(5):1122-1131. PubMed ID: 36840616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Continuous Glucose Monitoring Data Interpretation in the Age of Automated Insulin Delivery.
    Ekhlaspour L; Tabatabai I; Buckingham B
    J Diabetes Sci Technol; 2019 Jul; 13(4):645-663. PubMed ID: 31130007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
    Davis GM; Peters AL; Bode BW; Carlson AL; Dumais B; Vienneau TE; Huyett LM; Ly TT
    Diabetes Care; 2023 Apr; 46(4):742-750. PubMed ID: 36787903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Raghinaru D; Forlenza GP; Isganaitis E; Kudva YC; Lam DW; Levister C; O'Malley G; Church MM; Lum JW; Buckingham B; Brown SA
    J Diabetes Sci Technol; 2023 Jul; 17(4):935-942. PubMed ID: 35473359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.